The novel cancer-testis antigen A-kinase anchor protein 4 (AKAP4) is a potential target for immunotherapy of ovarian serous carcinoma

References

• Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012; 62:10 - 29; http://dx.doi.org/10.3322/caac.20138; PMID: 22237781
   PubMed Web of Science ®Google Scholar
• Suri A, Saini S, Sinha A, Agarwal S, Verma A, Parashar D, et al. Cancer testis antigens: A new paradigm for cancer therapy. Oncoimmunology 2012; 1:1194 - 6; http://dx.doi.org/10.4161/onci.20686; PMID: 23170277
   PubMed Web of Science ®Google Scholar
• Garg M, Chaurasiya D, Rana R, Jagadish N, Kanojia D, Dudha N, et al. Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer. Clin Cancer Res 2007; 13:1421 - 8; http://dx.doi.org/10.1158/1078-0432.CCR-06-2340; PMID: 17332284
   PubMed Web of Science ®Google Scholar
• Garg M, Kanojia D, Khosla A, Dudha N, Sati S, Chaurasiya D, et al. Sperm-associated antigen 9 is associated with tumor growth, migration, and invasion in renal cell carcinoma. Cancer Res 2008; 68:8240 - 8; http://dx.doi.org/10.1158/0008-5472.CAN-08-1708; PMID: 18922895
   PubMed Web of Science ®Google Scholar
• Kanojia D, Garg M, Gupta S, Gupta A, Suri A. Sperm-associated antigen 9, a novel biomarker for early detection of breast cancer. Cancer Epidemiol Biomarkers Prev 2009; 18:630 - 9; http://dx.doi.org/10.1158/1055-9965.EPI-08-0629; PMID: 19190149
   PubMed Web of Science ®Google Scholar
• Garg M, Kanojia D, Salhan S, Suri S, Gupta A, Lohiya NK, et al. Sperm-associated antigen 9 is a biomarker for early cervical carcinoma. Cancer 2009; 115:2671 - 83; http://dx.doi.org/10.1002/cncr.24293; PMID: 19326449
   PubMed Web of Science ®Google Scholar
• Garg M, Kanojia D, Suri S, Gupta S, Gupta A, Suri A. Sperm-associated antigen 9: a novel diagnostic marker for thyroid cancer. J Clin Endocrinol Metab 2009; 94:4613 - 8; http://dx.doi.org/10.1210/jc.2009-0703; PMID: 19820019
   PubMed Web of Science ®Google Scholar
• Kanojia D, Garg M, Saini S, Agarwal S, Kumar R, Suri A. Sperm associated antigen 9 expression and humoral response in chronic myeloid leukemia. Leuk Res 2010; 34:858 - 63; http://dx.doi.org/10.1016/j.leukres.2010.01.017; PMID: 20138665
   PubMed Web of Science ®Google Scholar
• Kanojia D, Garg M, Gupta S, Gupta A, Suri A. Sperm-associated antigen 9 is a novel biomarker for colorectal cancer and is involved in tumor growth and tumorigenicity. Am J Pathol 2011; 178:1009 - 20; http://dx.doi.org/10.1016/j.ajpath.2010.11.047; PMID: 21356354
   PubMed Web of Science ®Google Scholar
• Yu P, Yan L, Zhang H, Lin X, Zhao X. Expression and clinical significance of sperm-associated antigen 9 in patients with endometrial carcinoma. Int J Gynecol Cancer 2012; 22:87 - 93; http://dx.doi.org/10.1097/IGC.0b013e3182370f2e; PMID: 22146769
   PubMed Web of Science ®Google Scholar
• Ghafouri-Fard S, Modarressi MH. Cancer-testis antigens: potential targets for cancer immunotherapy. Arch Iran Med 2009; 12:395 - 404; PMID: 19566358
   PubMed Web of Science ®Google Scholar
• Odunsi K, Jungbluth AA, Stockert E, Qian F, Gnjatic S, Tammela J, et al. NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer. Cancer Res 2003; 63:6076 - 83; PMID: 14522938
   PubMed Web of Science ®Google Scholar
• Chiriva-Internati M, Yu Y, Mirandola L, Jenkins MR, Chapman C, Cannon M, et al. Cancer testis antigen vaccination affords long-term protection in a murine model of ovarian cancer. PLoS One 2010; 5:e10471; http://dx.doi.org/10.1371/journal.pone.0010471; PMID: 20485677
   PubMed Web of Science ®Google Scholar
• Mohapatra B, Verma S, Shankar S, Suri A. Molecular cloning of human testis mRNA specifically expressed in haploid germ cells, having structural homology with the A-kinase anchoring proteins. Biochem Biophys Res Commun 1998; 244:540 - 5; http://dx.doi.org/10.1006/bbrc.1998.8079; PMID: 9514854
   PubMed Web of Science ®Google Scholar
• Vermeij R, Daemen T, de Bock GH, de Graeff P, Leffers N, Lambeck A, et al. Potential target antigens for a universal vaccine in epithelial ovarian cancer. Clin Dev Immunol 2010; 2010:1505 - 15; http://dx.doi.org/10.1155/2010/891505; PMID: 20885926
   PubMed Web of Science ®Google Scholar
• Chiriva-Internati M, Raffaele F, Yu Y, Hamrick C, Gagliano N, Grizzi F, et al. AKAP4: a novel cancer testis antigen for multiple myeloma. Br J Haematol 2008; 140:465 - 68; http://dx.doi.org/10.1111/j.1365-2141.2007.06940.x; PMID: 18162122
   PubMed Web of Science ®Google Scholar
• Chiriva-Internati M, Yu Y, Mirandola L, D’Cunha N, Hardwicke F, Cannon MJ, et al. Identification of AKAP-4 as a new cancer/testis antigen for detection and immunotherapy of prostate cancer. Prostate 2012; 72:12 - 23; http://dx.doi.org/10.1002/pros.21400; PMID: 21520158
   PubMed Web of Science ®Google Scholar
• Taylor SE, Kirwan JM. Ovarian cancer: current management and future directions. Obstetrics, Gynaecol Reprod Med 2012; 22:33 - 7; http://dx.doi.org/10.1016/j.ogrm.2011.11.003
   Google Scholar
• Kepp O, Tesniere A, Zitvogel L, Kroemer G. The immunogenicity of tumor cell death. Curr Opin Oncol 2009; 21:71 - 6; http://dx.doi.org/10.1097/CCO.0b013e32831bc375; PMID: 19125021
   PubMed Web of Science ®Google Scholar
• Scudellari M. A ballsy search for cancer targets. Nat Med 2011; 17:916 - 8; http://dx.doi.org/10.1038/nm0811-916; PMID: 21818078
   PubMed Web of Science ®Google Scholar
• Tammela J, Uenaka A, Ono T, Noguchi Y, Jungbluth AA, Mhawech-Fauceglia P, et al. OY-TES-1 expression and serum immunoreactivity in epithelial ovarian cancer. Int J Oncol 2006; 29:903 - 10; PMID: 16964386
   PubMed Web of Science ®Google Scholar
• Valmori D, Qian F, Ayyoub M, Renner C, Merlo A, Gnjatic S, et al. Expression of synovial sarcoma X (SSX) antigens in epithelial ovarian cancer and identification of SSX-4 epitopes recognized by CD4+ T cells. Clin Cancer Res 2006; 12:398 - 404; http://dx.doi.org/10.1158/1078-0432.CCR-05-1902; PMID: 16428478
   PubMed Web of Science ®Google Scholar
• Sato E, Olson SH, Ahn J, Bundy B, Nishikawa H, Qian F, et al. Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci U S A 2005; 102:18538 - 43; http://dx.doi.org/10.1073/pnas.0509182102; PMID: 16344461
   PubMed Web of Science ®Google Scholar
• Bioley G, Dousset C, Yeh A, Dupont B, Bhardwaj N, Mears G, et al. Vaccination with recombinant NY-ESO-1 protein elicits immunodominant HLA-DR52b-restricted CD4+ T cell responses with a conserved T cell receptor repertoire. Clin Cancer Res 2009; 15:4467 - 74; http://dx.doi.org/10.1158/1078-0432.CCR-09-0582; PMID: 19531622
   PubMed Web of Science ®Google Scholar
• Diefenbach CS, Gnjatic S, Sabbatini P, Aghajanian C, Hensley ML, Spriggs DR, et al. Safety and immunogenicity study of NY-ESO-1b peptide and montanide ISA-51 vaccination of patients with epithelial ovarian cancer in high-risk first remission. Clin Cancer Res 2008; 14:2740 - 8; http://dx.doi.org/10.1158/1078-0432.CCR-07-4619; PMID: 18451240
   PubMed Web of Science ®Google Scholar
• Lee JH, Schütte D, Wulf G, Füzesi L, Radzun HJ, Schweyer S, et al. Stem-cell protein Piwil2 is widely expressed in tumors and inhibits apoptosis through activation of Stat3/Bcl-XL pathway. Hum Mol Genet 2006; 15:201 - 11; http://dx.doi.org/10.1093/hmg/ddi430; PMID: 16377660
   PubMed Web of Science ®Google Scholar
• Sharma S, Qian F, Keitz B, Driscoll D, Scanlan MJ, Skipper J, et al. A-kinase anchoring protein 3 messenger RNA expression correlates with poor prognosis in epithelial ovarian cancer. Gynecol Oncol 2005; 99:183 - 8; http://dx.doi.org/10.1016/j.ygyno.2005.06.006; PMID: 16005946
   PubMed Web of Science ®Google Scholar
• Tammela J, Jungbluth AA, Qian F, Santiago D, Scanlan MJ, Keitz B, et al. SCP-1 cancer/testis antigen is a prognostic indicator and a candidate target for immunotherapy in epithelial ovarian cancer.. Cancer Immun 2004; 4:10; PMID: 15487888
   PubMedGoogle Scholar